Minnesota Medical Cannabis Business & Marijuana Legal News

Report: Minnesota’s two medical cannabis firms post $2.4 million in red ink in 2018

Minnesota’s two medical marijuana companies, Leafline Labs and Minnesota Medical Solutions, lost a combined $2.4 million in 2018, continuing the losses that have marked the state’s program since it began in 2015. But top executives from the two companies told the St. Paul Pioneer Press they are optimistic because of recent legislative changes that will make […]

Read More

Smuggling case involving ex-execs at marijuana firm Vireo will proceed, court says

A Minnesota appellate court refused to dismiss interstate cannabis smuggling charges against two former Vireo Health executives, allowing the case to proceed to trial. Marijuana businesses have closely watched the situation because of its implications for MJ firms with affiliates in more than one state, the Rockland/Westchester Journal News noted. In this case, two Vireo Health officials […]

Read More

Q4 revenue jumps 72% for cannabis group Vireo amid state expansion

Vireo Health International, the Minneapolis-based, vertically integrated marijuana firm, reported revenue of $5.6 million for the fourth quarter of 2018, up 72% from the same period the prior year. Net loss for the quarter totaled $1.2 million versus profit of just over $293,000 in the same period 2017. The net loss was attributable in part […]

Read More

Vireo enters Arizona medical cannabis market

Vireo Health, a Minneapolis-based cannabis group, said it is expanding into Arizona with the acquisition of Arizona Natural Remedies (ANR). Vireo declined to disclose the value of the acquisition. The company, which started trading on the Canadian Securities Exchange earlier this month, will now operate in seven states. ANR operates a dispensary in Phoenix and an Amado-based cultivation […]

Read More

US marijuana firm Vireo Health launches on Canadian exchange

Vireo Health, a Minnesota-based multistate operating cannabis company, started trading Wednesday on the Canadian Securities Exchange. Vireo has growing, dispensary and processing operations in six states. Vireo is trading under the ticker symbol VREO. More details can be found here.

Read More

Minnesota adds Alzheimer’s as medical marijuana condition

Minnesota is adding Alzheimer’s disease as a qualifying condition for medical marijuana, a move that could provide a boost to MMJ sales. More than 94,000 Minnesota residents are afflicted with Alzheimer’s, according to the Alzheimer’s Association, but it’s unclear how many of those will enroll in the program. Those who do will be eligible to […]

Read More

Autism, sleep apnea now part of Minnesota’s medical marijuana program

Patients in Minnesota with autism or sleep apnea could start receiving medical marijuana on Wednesday, an expansion that could give the highly regulated market a small boost in MMJ demand. But it’s unclear whether that expansion – announced by regulators last November – and recent market growth will be enough for the state’s two vertically […]

Read More

What are the medical marijuana business hurdles in Minnesota?

Minnesota has one of the country’s most restrictive medical marijuana programs, and MMJ businesses in the state have experienced significant financial, management and legal issues. However, it isn’t necessarily all gloom and doom when it comes to the future of Minnesota’s MMJ businesses. Nic Easley, a national cannabis consultant and CEO of Denver-based 3C Consulting, […]

Read More

Minnesota medical marijuana company LeafLine loses CEO

The chief executive of one of Minnesota’s two medical marijuana manufacturers has left the company after years of financial losses.

Andrew Bachman, LeafLine Labs’ co-founder and its chief executive since 2016, is no longer with the company “in any official capacity,” the company said Thursday in a statement to the Associated Press.

Read More

Chart: Minnesota medical marijuana patient count rises with approval of PTSD, pain

Minnesota has been among the most restrictive medical marijuana markets in the United States for years, with only two licensed producers serving all registered MMJ patients, a ban on edibles and cannabis flower and a narrow qualifying conditions list. Those factors add up to a small patient pool and questions about whether Minnesota’s two vertically […]

Read More